[Writing Sample – Healthcare & Pharmacology]
- Author Role: Licensed Japanese Pharmacist (Research, Fact-Checking, and Writing)
- Key Highlights:
- Explains the neurobiological mechanism of antihistamine-induced drowsiness using PET study data (brain H1 receptor occupancy) and the concept of “impaired performance.”
- Compares first- and second-generation antihistamines using official Japanese OTC and prescription package inserts (PMDA) as primary sources.
- Translates complex pharmacological concepts into clear, actionable advice for consumers.
The primary reason oral allergy medications cause drowsiness is that antihistamines act not only on the nasal passages, but also on the brain. However, the likelihood of sedation varies significantly depending on the active ingredient. In this guide, we will break down the mechanism behind antihistamine-induced drowsiness and key points to check when selecting over-the-counter (OTC) allergy medications.
- Why Do Allergy Medications Make You Sleepy?
- You Can Experience Impaired Performance Without Feeling Drowsy
- Precautions Vary by Active Ingredient
- 5 Checkpoints for Choosing a Non-Drowsy OTC Allergy Medication
- “Non-Drowsy” Does Not Mean “Zero Drowsiness”
- Who Should Consult a Healthcare Professional Before Use?
- Summary
- References
Why Do Allergy Medications Make You Sleepy?

Allergy symptoms such as sneezing and a runny nose are triggered by histamine, a chemical released by the immune system. Antihistamines relieve these symptoms by blocking H1 receptors, the binding sites for histamine.
However, H1 receptors are also present in the brain, where histamine helps regulate wakefulness and alertness. When an antihistamine crosses into the brain and blocks these central H1 receptors, it leads to drowsiness and reduced cognitive function.
A research group at Tohoku University used positron emission tomography (PET) to measure the extent to which different antihistamines occupy H1 receptors in the human brain (brain H1 receptor occupancy) [1]. Their findings showed that higher receptor occupancy closely correlated with both the clinical incidence of drowsiness and measurable declines in cognitive performance [1].
In short, the more easily an ingredient enters the brain, the more likely it is to make you feel sleepy.
You Can Experience Impaired Performance Without Feeling Drowsy

One critical precaution is that your concentration and judgment may decline even if you do not consciously feel sleepy.
In an experiment by the same research group, administering 2 mg of d-chlorpheniramine—a first-generation antihistamine—resulted in a 77% brain H1 receptor occupancy rate [2]. While participants showed statistically significant delays in reaction time and lower accuracy on visual cognitive tasks, they reported almost no noticeable change in subjective sleepiness [2].
This phenomenon—a decline in cognitive and psychomotor performance without subjective awareness of drowsiness—is known as impaired performance. Rather than assuming you are fine simply because you do not feel tired, it is essential to follow the precautions listed on the medication’s package insert.
Precautions Vary by Active Ingredient

Antihistamines are broadly categorized into first-generation and second-generation agents based on when they were developed and their pharmacological properties. However, not all second-generation antihistamines carry the same level of sedation risk. Comparing official Japanese OTC and prescription package inserts reveals clear differences:
| Active Ingredient (Example Brand in Japan) | Classification | Driving / Machinery Warning | Typical Dosage |
|---|---|---|---|
| Chlorpheniramine, etc. (found in combination cold medicines) | First-generation | “Do not drive or operate machinery after taking this medication.” [3] | Varies by product |
| Cetirizine hydrochloride (Stonarhini Z Gel) | Second-generation | “Do not drive or operate machinery after taking this medication.” [4] | Once daily, before bedtime [4] |
| Fexofenadine hydrochloride (Allegra FX) | Second-generation | No driving restriction listed under “Do Not Use / Precautions” [5] | Twice daily, morning and evening [5] |
Note: Based on official Japanese package inserts and consumer information sheets [3, 4, 5]. Always check the latest package insert before purchase.
In post-marketing surveillance of the prescription version of cetirizine (Zyrtec Tablets), drowsiness (2.6%) was reported among the primary adverse reactions [4].
5 Checkpoints for Choosing a Non-Drowsy OTC Allergy Medication

1. Check the Active Ingredient, Not Just the Brand Name
Look at the “Active Ingredients” section on the back of the box rather than relying solely on the brand name. Products under the same brand umbrella can contain completely different active ingredients.
2. Check the “Do Not Use / Precautions” Section for Driving Warnings
If the package insert states, “Do not drive or operate machinery after taking this medication,” the product carries a recognized risk of drowsiness [3, 4]. If you need to drive, operate machinery, take an exam, or attend important meetings, checking for this warning is the most practical way to choose safely.
3. Match the Dosing Schedule to Your Daily Routine
Some OTC options are taken once daily before bedtime, while others are taken twice daily (morning and evening) [4, 5]. Choose a regimen that fits your lifestyle to help prevent missed doses.
4. Avoid Doubling Up on Antihistamines
Consumer instructions for products like Allegra FX state that you should not take other allergy medications or oral medicines containing antihistamines—such as cold remedies, cough suppressants, motion sickness medications, or sleep aids—while using the product [5]. Always check ingredient labels to avoid accidental duplication.
5. Avoid Alcohol Before and After Taking the Medication
Package inserts for both Allegra FX and Stonarhini Z Gel instruct users to avoid drinking alcohol before and after taking the medication, as alcohol can intensify central nervous system side effects [4, 5].
“Non-Drowsy” Does Not Mean “Zero Drowsiness”
Individual sensitivity to antihistamines varies. Even if a medication has no driving restriction on its label, if you experience drowsiness or sluggishness, refrain from driving or hazardous activities and consult a pharmacist or registered seller (Tourokuhanbaisha).
Additionally, never reduce your dose on your own to prevent drowsiness, nor take extra doses if symptoms persist. Always follow the recommended dosage and administration guidelines.
Who Should Consult a Healthcare Professional Before Use?

According to official consumer guidance for OTC fexofenadine (Allegra FX), the following individuals should consult a doctor or pharmacist before purchasing [5]:
- People currently receiving medical treatment from a physician
- People who are unsure whether their symptoms are caused by allergic rhinitis or another condition such as the common cold
- People diagnosed with other allergic conditions, such as bronchial asthma or atopic dermatitis
- People experiencing severe nasal congestion
- Pregnant women (or those who may be pregnant) and older adults
Breastfeeding mothers are advised either not to take these medications or to avoid breastfeeding while taking them [4, 5]. Furthermore, neither Allegra FX nor Stonarhini Z Gel is approved for children under 15 years of age [4, 5].
If OTC medications fail to relieve your symptoms, or if you experience severe symptoms every allergy season, consult a physician for a tailored treatment plan.
Summary
- Allergy medications cause drowsiness when antihistamines block H1 receptors in the brain as well as the nose.
- Cognitive and motor performance can decline even without a noticeable feeling of sleepiness (impaired performance).
- Even among second-generation antihistamines, driving restrictions differ depending on the specific ingredient.
- Check the active ingredient and the “Do Not Use / Precautions” section before buying, and consult a pharmacist if you are unsure which option is right for you.
Disclaimer: This article is for general informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Product labeling may be updated; always read the latest package insert and consult a physician or pharmacist before using any medication.
References
- Yanai K, Watanabe T, Okamura N, Ito M. “Neuropharmacological studies of human brain using PET and drug discovery.” Folia Pharmacologica Japonica (Nippon Yakurigaku Zasshi). 1998;112(Suppl):48–52. (In Japanese)
- Grants-in-Aid for Scientific Research Database (KAKEN). “Study on higher brain function using 3D-PET and brain activation methods” (Principal Investigator: Kazuhiko Yanai, FY1997). (In Japanese)
- Ministry of Health, Labour and Welfare (MHLW). Notification on Partial Revision of Precautions in Package Inserts for Cold Remedies, etc. (January 17, 2023). (In Japanese)
- Pharmaceuticals and Medical Devices Agency (PMDA). “Stonarhini Z Gel Package Insert” (Sato Pharmaceutical Co., Ltd.) / “Zyrtec Tablets 5mg / 10mg Electronic Package Insert” (UCB Japan Co., Ltd., Revised April 2025, 2nd Edition). (In Japanese)
Sanofi K.K. “Allegra FX Consumer Information Sheet for Proper Purchase.” (In Japanese)

コメント